Retrospective study on clinical characteristics of 373 patients with HBeAg-negative chronic hepatitis B
Jiang Ji
Abstract
Jiang Ji
Abstract
Objective To investigate the clinical characteristics of HBeAg-negative chronic hepatitis B(CHB)and provide evidence for the prevention and treatment protocols.Methods Retrospective study was carried out on 732 cases of CHB and hepatitis B cirrhosis(HBC).Patients were divided into HBeAg-negative group and HBeAg-positive group based on HBeAg status.Age,duration of disease and virological features were compared between the 2 groups.Results 373 patients(51%)were HBeAg negative and 359(49%)were HBeAg positive.The mean age in HBeAg-negative group was(50.2±12.8)years,older than that in HBeAg-positive group which the mean age was(38.8±13.1)years(P0.05).Duration of HBsAg positive in HBeAg-negative group was 12.0 years,longer than that in HBeAg-positive group 6.0 years(P0.05).The median serum HBV DNA level in HBeAg-negative group was 1.01×104(103,4.9×108)copies/ml,lower than that in HBeAg-positive group[1.30×106(103,7.11×109)copies/ml](P0.05).The median serum HBsAg levels were 3685U/ml in HBeAg-negative group and 3530U/ml in HBeAg-positive group,and the difference between them was not significant(P0.05).About 17.4% of HBeAg-negative patients developed primary liver cancer,and the proportion was higher than that of HBeAg-positive patients(6.69%)(P0.05).Conclusion HBeAgnegative patients account for considerable proportion in the patients with CHB and HBV-related cirrhosis.They are much older,and have longer duration of disease,lower serum HBV DNA level,and more commonly develop into primary liver cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical characteristics of HBeAg-negative chronic hepatitis B(CHB)and provide evidence for the prevention and treatment protocols.Methods Retrospective study was carried out on 732 cases of CHB and hepatitis B cirrhosis(HBC).Patients were divided into HBeAg-negative group and HBeAg-positive group based on HBeAg status.Age,duration of disease and virological features were compared between the 2 groups.Results 373 patients(51%)were HBeAg negative and 359(49%)were HBeAg positive.The mean age in HBeAg-negative group was(50.2±12.8)years,older than that in HBeAg-positive group which the mean age was(38.8±13.1)years(P0.05).Duration of HBsAg positive in HBeAg-negative group was 12.0 years,longer than that in HBeAg-positive group 6.0 years(P0.05).The median serum HBV DNA level in HBeAg-negative group was 1.01×104(103,4.9×108)copies/ml,lower than that in HBeAg-positive group[1.30×106(103,7.11×109)copies/ml](P0.05).The median serum HBsAg levels were 3685U/ml in HBeAg-negative group and 3530U/ml in HBeAg-positive group,and the difference between them was not significant(P0.05).About 17.4% of HBeAg-negative patients developed primary liver cancer,and the proportion was higher than that of HBeAg-positive patients(6.69%)(P0.05).Conclusion HBeAgnegative patients account for considerable proportion in the patients with CHB and HBV-related cirrhosis.They are much older,and have longer duration of disease,lower serum HBV DNA level,and more commonly develop into primary liver cancer.
Key concepts: Medicine, HBeAg, Cirrhosis, Gastroenterology, Internal medicine, Chronic hepatitis, HBsAg, Hepatitis B